Deals & Cases
MLL Legal advises betterview on asset sale to stock-listed EuroEyes
MLL Legal advised betterview, a leading Swiss provider of vision correction services, on the sale of its medical practices in Switzerland and the United Kingdom to the Hong Kong stock-listed EuroEyes Group.
MLL Legal advised betterview AG, a leading Swiss provider of laser eye surgery and long-term vision correction, on the sale of its medical practices, including several laser clinics and a surgery theatre, in Switzerland and the United Kingdom to EuroEyes International Eye Clinic Limited, listed on the Hong Kong stock exchange (1846.HK).
Betterview is a provider of cutting-edge laser eye surgery and long-term vision correction with practices in Switzerland and the United Kingdom. EuroEyes is a leading European clinic group for refractive and cataract surgery with practices in Germany, the UK, Denmark, and China. With EuroEyes, betterview has found the ideal partner to pursue its vision and further its expansion in Switzerland and abroad. The transaction will give Swiss patients direct access to international top-tier medicine in presbyopia correction, laser eye treatment, and refractive lens exchange, and marks EuroEyes’ entry into the Swiss market.
The MLL team was led by partner Dr. Marc A. Schamaun (Corporate/M&A) and included partners Thomas Nabholz (Tax), Thomas Kälin (Employment), Samuel Ljubicic (Finance), senior associate Dr. Philipp Estermann (Corporate/M&A), and associates Fabian Bögli (Corporate/M&A) and Karim Steiner (Notary).
Stifel Investment Banking acted as financial advisor to betterview.